mementor.de

What It Is

mementor is a digital health company based in Leipzig, Germany. It was originally founded in Switzerland in 2014, moved its headquarters to Leipzig in 2020, and became part of ResMed in Germany in 2022. The company focuses on digital sleep medicine, aiming to lower the barrier for patients to access evidence-based treatment through “prescription apps” and to help address gaps in traditional healthcare provision.

Core Capabilities

Its flagship product, somnio, is a digital health application for sleep-onset and sleep-maintenance disorders—in other words, insomnia. According to the site, somnio was jointly developed by sleep medicine specialists and psychologists. Its content is based on cognitive behavioral therapy for insomnia, or KVT-I, and has been converted into multiple app modules. The app can adapt to individual needs based on personal information and helps users improve their sleep behavior over a three-month period. Its effectiveness has been demonstrated through randomized scientific studies, and it is described as a German DiGA “App auf Rezept” that has been permanently approved since October 2020.

Pricing and Compliance

The official website does not publish standard SaaS plans, per-user pricing, or enterprise procurement options. What can be confirmed is that somnio follows Germany’s prescription digital health application pathway and, after passing review and demonstrating positive medical effects, can be reimbursed by statutory health insurance. Security and compliance are among mementor’s strengths: the company holds DIN EN ISO/IEC 27001 information security certification and DIN EN ISO 13485 medical device quality management system certification, and maintains these standards through annual internal and external audits.

Pros and Cons

Its strengths lie in its focused positioning, relatively strong medical evidence base, clear prescription-app status, and synergy with ResMed’s sleep medicine resources. For patients, digital CBT-I can improve access to treatment, especially in regions with limited medical resources. Its limitations are that the website is more oriented toward company information and lacks detailed explanations of the product interface, usage workflow, APIs, third-party integrations, team permissions, and commercial pricing. As a result, it should not be evaluated like a general-purpose enterprise SaaS product.

Who It’s For and Access from China

mementor is better suited to insomnia patients within the German healthcare system, sleep medicine physicians, and related healthcare providers, where it can serve as a low-barrier supplement to traditional treatment. Access from China is not mentioned in the source text, and actual accessibility, regulatory availability, and insurance reimbursement status are all unknown.